Xanthine oxidase is an enzyme that breaks down purines, the building blocks found in DNA and certain foods, into uric acid. It does this in two steps: first converting hypoxanthine into xanthine, then converting xanthine into uric acid. That’s its primary housekeeping job. But the enzyme also generates reactive oxygen species as a byproduct, which links it to a surprisingly wide range of health conditions, from gout to heart disease.
How It Breaks Down Purines
Every cell in your body contains purines, and when those cells die or when you digest purine-rich foods (organ meats, shellfish, beer), the purines need to be broken down and cleared out. Xanthine oxidase handles the final stage of that process. It converts hypoxanthine, an intermediate waste product, into xanthine, and then converts xanthine into uric acid. Uric acid then travels through the bloodstream to the kidneys, where most of it is filtered out in urine.
The enzyme is found throughout the body but is most active in the liver and intestines. Milk is also one of the richest natural sources of xanthine oxidase, where it plays a completely different role (more on that below).
The Free Radicals It Produces
What makes xanthine oxidase medically interesting is not just the uric acid it produces but the way it produces it. During each reaction cycle, the enzyme transfers electrons to oxygen molecules, generating superoxide and hydrogen peroxide as byproducts. A fully reduced molecule of the enzyme generates two molecules of hydrogen peroxide and two molecules of superoxide for every reaction cycle it completes.
These reactive oxygen species aren’t always harmful. At normal levels, superoxide and hydrogen peroxide act as signaling molecules that help regulate inflammation and immune responses. The enzyme can also generate nitric oxide, another important signaling molecule involved in blood vessel dilation.
Problems arise when the enzyme becomes overactive. Excess superoxide can react with nitric oxide to form peroxynitrite, a particularly damaging compound. In the presence of iron, hydrogen peroxide can also generate hydroxyl radicals, one of the most destructive free radicals in the body. Together, these reactive species overwhelm the body’s antioxidant defenses and create what’s called oxidative stress.
The Connection to Gout
Because xanthine oxidase is the sole source of uric acid production, its activity directly determines how much uric acid ends up in your blood. When uric acid levels climb above roughly 6.8 mg/dL, the uric acid can crystallize and deposit in joints, triggering the intense pain and swelling of gout. Elevated uric acid can also contribute to uric acid kidney stones when the crystals form in the urinary tract instead.
This is why medications that block xanthine oxidase are the preferred first-line treatment for gout. Allopurinol, the most widely prescribed option, is structurally similar to hypoxanthine and competes with it for the enzyme’s active site, slowing uric acid production. At higher concentrations, it blocks the enzyme through a different mechanism entirely. It also causes a buildup of hypoxanthine and xanthine, which in turn signals the body to slow down purine production overall.
Febuxostat works differently. It’s not a purine look-alike, so it blocks the enzyme without interfering with purine or pyrimidine synthesis. Both medications aim for the same clinical target: bringing serum uric acid below 6 mg/dL, the threshold recommended by the American College of Rheumatology to prevent future gout flares.
Its Role in Cardiovascular Disease
Xanthine oxidase is one of two major enzyme systems responsible for producing reactive oxygen species in blood vessels (the other being NADPH oxidase). The superoxide and hydrogen peroxide it generates can damage the inner lining of blood vessels, a condition called endothelial dysfunction. This damage reduces the vessels’ ability to relax and dilate properly, which is an early step in the development of atherosclerosis, high blood pressure, and heart failure.
For years, researchers debated whether uric acid itself was the problem or simply a marker of something else. The current understanding is that uric acid is likely a marker of xanthine oxidase activity rather than a direct cause of vascular damage. The real culprit is the oxidative stress generated during uric acid production. This distinction matters clinically: studies have shown that improvements in blood vessel function from blocking xanthine oxidase come from reducing the reactive oxygen species, not just from lowering uric acid levels. There’s also evidence linking oxidative stress from this enzyme to left ventricular hypertrophy, a thickening of the heart muscle that increases the risk of heart failure.
A Surprising Role in Breast Milk
One of the more unexpected functions of xanthine oxidase has nothing to do with purine breakdown. In the mammary gland during lactation, the enzyme plays a structural role in packaging and secreting fat droplets into milk. Xanthine oxidase is a major component of the milk fat globule membrane, the thin coating that surrounds each fat droplet in breast milk. It forms a complex with two other proteins (butyrophilin and adipophilin) that acts like a bridge, connecting fat droplets inside the cell to the cell’s outer membrane so the droplets can be released into milk.
The enzyme makes up 1 to 2 percent of the soluble protein in the lactating mammary gland of cattle and mice, making it one of the most abundant proteins in this tissue. Interestingly, the version of xanthine oxidase found in human milk has a markedly reduced ability to carry out its usual purine-degrading chemical reaction. This supports the idea that its role in milk production is primarily structural rather than enzymatic.
When Activity Becomes Elevated
Xanthine oxidase activity tends to rise in conditions involving tissue damage and inflammation. In healthy adults, serum levels of the enzyme average around 4 mg/dL, but they can climb significantly in disease states. Chronic kidney disease is a particularly important factor: as kidney function declines, uric acid clearance drops while xanthine oxidase activity often increases, doubling the odds of experiencing a gout flare for each advancing stage of kidney disease.
Conditions associated with ischemia-reperfusion injury, where blood flow is temporarily cut off and then restored (such as during a heart attack or organ transplant), also trigger spikes in xanthine oxidase activity. When oxygen floods back into tissues, the enzyme rapidly produces large amounts of superoxide and hydrogen peroxide, contributing to tissue damage beyond what the initial lack of blood flow caused.